NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/01/2026
Back to search
Official data from USPTO
REVLIMID
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
04/21/2026
Trademark type
Word
Nice classes
5
Filing date
08/21/2003
Registration date
03/28/2006
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/01/2026
Last transaction
04/21/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/19/2004
First use in commerce
06/03/2004
Drawing code
4
Owner type
03
Owner location
Summit, NJ, US
Examiner
CASE, LEIGH CAROLINE
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
C. C. (pessoa física)
C. C. (pessoa física)
Representatives
Marilyn F. Kelly Bristol-Myers Squibb Company
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparationscytokine inhibitory drugs; pharmaceutical preparations that modulate the immune system
Publications
History of USPTO decisions and trademark events.
47 publications found
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
04/01/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/01/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/01/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
01/21/2026
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/28/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
12/09/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
12/09/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
12/09/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/09/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/09/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
12/09/2022
NOSU
NOTICE OF SUIT
08/06/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/29/2015
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
04/15/2015
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/15/2015
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/15/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/15/2015
E89R
TEAS SECTION 8 & 9 RECEIVED
04/01/2015
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
03/28/2015
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
09/23/2011
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
09/23/2011
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/23/2011
E815
TEAS SECTION 8 & 15 RECEIVED
08/23/2011
R.PR
REGISTERED-PRINCIPAL REGISTER
03/28/2006
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
02/16/2006
ALIE
ASSIGNED TO LIE
02/10/2006
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
02/07/2006
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/07/2006
EX3G
SOU EXTENSION 3 GRANTED
02/07/2006
IUAF
USE AMENDMENT FILED
01/20/2006
EXT3
SOU EXTENSION 3 FILED
01/20/2006
EEXT
SOU TEAS EXTENSION RECEIVED
01/20/2006
EISU
TEAS STATEMENT OF USE RECEIVED
01/20/2006
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/20/2006
EX2G
SOU EXTENSION 2 GRANTED
07/15/2005
EXT2
SOU EXTENSION 2 FILED
07/06/2005
EEXT
SOU TEAS EXTENSION RECEIVED
07/06/2005
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
06/16/2005
EX1G
SOU EXTENSION 1 GRANTED
02/17/2005
EXT1
SOU EXTENSION 1 FILED
02/03/2005
EEXT
SOU TEAS EXTENSION RECEIVED
02/03/2005
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
08/03/2004
PUBO
PUBLISHED FOR OPPOSITION
05/11/2004
NPUB
NOTICE OF PUBLICATION
04/21/2004
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/08/2004
DOCK
ASSIGNED TO EXAMINER
03/08/2004
Continuous trademark protection
Get notified about every new filing that threatens REVLIMID or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.